Disability News and Research

RSS

Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

Researchers have new insight into the complex interchange that can raise blood levels of unhealthy lipids, or fat, in type 1 diabetes, and early evidence that a drug under study to block cancer cell growth can restore healthier levels.

8 Feb 2016

Pivotal IDE clinical trial results for Cerapedics' i-FACTOR bone graft in ACDF procedures published in journal Spine

Cerapedics, a privately-held orthobiologics company, announced today results from a pivotal FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR Peptide Enhanced Bone Graft in anterior cervical discectomy and fusion (ACDF) procedures have been electronically published in the peer-reviewed journal Spine.

8 Feb 2016

New AGS guidance aims to transform approaches to healthcare for older patients

New guidance from the American Geriatrics Society aims to transform approaches to healthcare for our increasingly diverse older population. Developed by a committee of experts in ethnogeriatrics (the study of how ethnicity and culture impact the health and well-being of older people), "Achieving High-Quality Multicultural Geriatric Care" outlines present health disparities and the need for sensitivity to culture and health literacy when working with older individuals.

5 Feb 2016

People with traumatic brain injuries may have buildup of plaques related to Alzheimer's disease

A new study suggests that people with brain injuries following head trauma may have buildup of the plaques related to Alzheimer's disease in their brains. The research is published in the February 3, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.

4 Feb 2016

Natalizumab shows relapse prevention benefits over fingolimod in MS

Natalizumab may be superior to fingolimod for preventing relapses during the first year of treatment in patients with relapsing–remitting multiple sclerosis, observational study findings show.

4 Feb 2016

UAB research explores neurofibromatosis type 1

It is easy to tell a medical research story that has a simple and dramatic moment. But disease is often much more complex, and the work to understand it can be painstaking. A vivid example of that is seen in the University of Alabama at Birmingham Medical Genomics Laboratory, headed by Ludwine Messiaen, Ph.D., professor of genetics. This lab offers clinical genetic testing for a broad array of common and rare genetic disorders.

3 Feb 2016

WHO calls on governments to rate movies that portray tobacco use

The World Health Organization is calling on governments to rate movies that portray tobacco use in a bid to prevent children and adolescents from starting to smoke cigarettes and use other forms of tobacco.

2 Feb 2016

People with disabilities, caregivers, veterans and healthcare professionals to attend 2016 Abilities Expo

Thousands of people with disabilities, their families, caregivers, seniors, wounded veterans and healthcare professionals are expected to attend Abilities Expo on February 5-7, 2016 at the Los Angeles Convention Center, West Hall A. Admission is free and the new show hours will get attendees home in time to watch the Super Bowl: Friday 11 am to 5 pm, Saturday 10 am to 6 pm and Sunday 10 am to 2 pm.

1 Feb 2016

U of M's 'Ask About Aspirin' initiative aims to reduce incidence of first heart attack or stroke

Cardiovascular diseases are the leading causes of death and disability in the United States, accounting for nearly one-third of all deaths. The diseases also create an immense national health economic burden.

30 Jan 2016

Fingolimod trial INFORMS primary progressive MS strategy

Fingolimod is unable to slow disability progression or brain volume loss in patients with primary progressive multiple sclerosis, show the findings of the INFORMS study.

29 Jan 2016

Clinicoradiological syndromes allow rapid recognition of EV71 neurological problems

Severe enterovirus 71 neurological disease in children predominantly involves the spinal cord and brainstem and can be quickly recognised using the World Health Organisation classification of clinicoradiological syndromes, study findings suggest.

29 Jan 2016

Dysport phase III study results in children with cerebral palsy with lower limb spasticity published in Pediatrics

Ipsen today announced that the scientific journal Pediatrics published the detailed results of the phase III randomized study showing both the efficacy and the safety of Dysport in the treatment of dynamic equinus foot deformity, a condition associated with cerebral palsy in children.

28 Jan 2016

New findings offer roadmap for development of novel therapies to target common brain disorders

Scientists have pinpointed the cells that are likely to trigger common brain disorders, including Alzheimer's disease, Multiple Sclerosis and intellectual disabilities.

28 Jan 2016

CosmosID announces $6M in Series B funding round

CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-generation DNA sequencing, announced $6M in Series B funding.

28 Jan 2016

Opioid medication does not improve physical function in patients with neuropathic pain

Opioids such as morphine, codeine and Tylenol 3 can be effective for treating pain, however, a new University of Alberta study finds that patients with neuropathic pain taking opioids report no improvements in physical functioning compared to those who were not prescribed opioids.

25 Jan 2016

Twice-daily stimulation of vagus nerve with gammaCore nVNS device reduces number of migraine attacks

A study published in the Journal of Headache and Pain, carried out by Dr. Thomas Kinfe of the University of Bonn, found that twice daily stimulation of the vagus nerve with the hand-held gammaCore nVNS device reduced the number of headache days per month from 14.7 to 8.9 (p<0.001) and the number of monthly migraine attacks from 7.3 to 4.5 (p<0.001).

21 Jan 2016

Concussions related to sports and recreation activities affect millions of Americans

Every year, between 3 million and 4 million Americans suffer concussions in sports and recreation. Head impacts and concussions caused by contact sports are a quickly growing epidemic among young athletes.

19 Jan 2016

Wearing helmet could cut life-threatening sledding injuries in kids

With the coldest months of the year upon us, it’s only a matter of time until the first snowfall of the season hits. Sledding, a seasonal favorite for children of all ages seeking thrills, is probably high on kids’ to-do lists as the first flakes hit the ground.

18 Jan 2016

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

Novartis announced today that the US Food and Drug Administration has approved Cosentyx (secukinumab) for two new indications - the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).

17 Jan 2016

First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that the first patient has been enrolled in its Phase II CIRCLE study evaluating the efficacy and safety of multiple doses of ocriplasmin in inducing total posterior vitreous detachment (PVD) in patients with non-proliferative diabetic retinopathy (NPDR).

13 Jan 2016

Disability News and Research

Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

Pivotal IDE clinical trial results for Cerapedics' i-FACTOR bone graft in ACDF procedures published in journal Spine

New AGS guidance aims to transform approaches to healthcare for older patients

People with traumatic brain injuries may have buildup of plaques related to Alzheimer's disease

Natalizumab shows relapse prevention benefits over fingolimod in MS

UAB research explores neurofibromatosis type 1

WHO calls on governments to rate movies that portray tobacco use

People with disabilities, caregivers, veterans and healthcare professionals to attend 2016 Abilities Expo

U of M's 'Ask About Aspirin' initiative aims to reduce incidence of first heart attack or stroke

Fingolimod trial INFORMS primary progressive MS strategy

Clinicoradiological syndromes allow rapid recognition of EV71 neurological problems

Dysport phase III study results in children with cerebral palsy with lower limb spasticity published in Pediatrics

New findings offer roadmap for development of novel therapies to target common brain disorders

CosmosID announces $6M in Series B funding round

Opioid medication does not improve physical function in patients with neuropathic pain

Twice-daily stimulation of vagus nerve with gammaCore nVNS device reduces number of migraine attacks

Concussions related to sports and recreation activities affect millions of Americans

Wearing helmet could cut life-threatening sledding injuries in kids

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

Industry Focus eBook - Cell biology (5th edition) eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News